Sotac Pharmaceuticals Limited (NSE:SOTAC)
India · Delayed Price · Currency is INR 128.50
0.00 (0.00%)
At close: Oct 23, 2025
Sotac Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Sotac Pharmaceuticals had annual revenue of 1.00B INR, down -3.57%. Sotac Pharmaceuticals had revenue of 238.31M in the quarter ending March 31, 2025, a decrease of -10.23%.
Revenue
1.00B
Revenue Growth
-3.57%
P/S Ratio
1.41
Revenue / Employee
7.89M
Employees
127
Market Cap
1.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.00B | -37.09M | -3.57% |
| Mar 31, 2024 | 1.04B | 264.82M | 34.18% |
| Mar 31, 2023 | 774.83M | 43.32M | 5.92% |
| Mar 31, 2022 | 731.52M | 243.09M | 49.77% |
| Mar 31, 2021 | 488.43M | 202.40M | 70.76% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.04T |
| State Bank of India | 3.50T |
| Larsen & Toubro | 2.69T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| ICICI Bank | 1.91T |
| Bharti Airtel | 1.84T |